venture capital conference in Atlanta.
The conference, titled “Where Innovation Meets Opportunity,” is set for Nov. 8-10 at the InterContinental Buckhead Hotel.
The early-stage companies include:
Abeome Corporation (Athens, Ga.)
Addrenex Pharmaceuticals, Inc. (Morrisville, N.C.)
AerovectRx Corporation (Atlanta, Ga.)
AudioFusion Inc. (Winston Salem, N.C.)
BioDtech, Inc. (Nashville, Tenn.)
Celtaxsys, Inc. (Atlanta)
InterveXion Therapeutics, LLC (Little Rock, Ark.)
IntraTherm LLC (Little Rock, Ark.)
NanoVici, Inc. (Atlanta)
OcuCure Therapeutics (Roanoke, Vir.)
Precision BioSciences, Inc. (Durham, N.C.)
Precision Human BioLaboratories, Inc. (Cary, N.C.)
ViewRay, Inc. (Gainesville, Fla.)
The 14 later-stage companies include:
Adlyfe Inc. (Rockville, Md.)
AGTC (Alachua, Fla.)
Aldagen, Inc. (Durham, N.C.)
Altor Bioscience Corporation (Miramar, Fla.)
Argos Therapeutics, Inc. (Durham, N.C.)
Biolex Therapeutics (Pittsboro, N.C.)
DiaKine Therapeutics, Inc. (Charlottesville, Vir.)
Nanotherapeutics, Inc. (Alachua, Fla.)
NeoVista, Inc. (Atlanta)
NephroGenex (Cary, N.C.)
Phase Bioscience, Inc. (Durham, N.C.)
Regado Biosciences (Durham, N.C.)
RFS Pharma, LLC (Tucker, Ga.)
Serenex, Inc. (Durham, N.C.)
The SE BIO conference has been put on annually since 1999.
Copyright 2023 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.